FDA De Novo for Fziomed Oxiplex Gel

FzioMed Oxiplex Products

Fziomed received De Novo classification and marketing authorization from FDA for Oxiplex gel, indicated for reducing postoperative leg pain and neurological symptoms in adult patients undergoing lumbar spine procedures. Oxiplex is now the first and only FDA authorized intraoperative gel specifically designed for this indication.

Fziomed's...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.

JV

Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



Contact Us

0